Gene · 10935
Papers2,082
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
141 to 160 of 2,082
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| High Yield of Functional Dopamine-like Neurons Obtained in NeuroForsk 2.0 Medium to Study Acute and Chronic Rotenone Effects on Oxidative Stress, Autophagy, and Apoptosis. | Int J Mol Sci | 2023 | 37958728 | PubTator, text mining | PubMed |
| Harnessing Ferroptosis to Overcome Drug Resistance in Colorectal Cancer: Promising Therapeutic Approaches. | Cancers (Basel) | 2023 | 37958383 | PubTator, text mining | PubMed |
| Correction: Comprehensive analysis of peroxiredoxins expression profiles and prognostic values in breast cancer. | Biomark Res | 2023 | 37941057 | PubTator, text mining | PubMed |
| MUC1-C integrates aerobic glycolysis with suppression of oxidative phosphorylation in triple-negative breast cancer stem cells. | iScience | 2023 | 37915591 | PubTator, text mining | PubMed |
Identification of Antioxidant Metabolites from Five Plants (Calophyllum inophyllum, Gardenia taitensis, Curcuma longa, Cordia subcordata, Ficus prolixa) of the Polynesian Pharmacopoeia and Cosmetopoeia for Skin Care. | Antioxidants (Basel) | 2023 | 37891949 | PubTator, text mining | PubMed |
| Transcriptomic Characterization of Copper-Binding Proteins for Predicting Prognosis in Glioma. | Brain Sci | 2023 | 37891828 | PubTator, text mining | PubMed |
| Mitochondrial complex I ROS production and redox signaling in hypoxia. | Redox Biol | 2023 | 37871533 | PubTator, text mining | PubMed |
| The EMT factor ZEB1 paradoxically inhibits EMT in BRAF-mutant carcinomas. | JCI Insight | 2023 | 37870961 | PubTator, text mining | PubMed |
| Single cell and bulk transcriptome analysis identified oxidative stress response-related features of Hepatocellular Carcinoma. | Front Cell Dev Biol | 2023 | 37842089 | PubTator, text mining | PubMed |
| Calcein-Modified CeO2 for Intracellular ROS Detection: Mechanisms of Action and Cytotoxicity Analysis In Vitro. | Cells | 2023 | 37830630 | PubTator, text mining | PubMed |
Changes to insulin sensitivity in glucose clearance systems and redox following dietary supplementation with a novel cysteine-rich protein: A pilot randomized controlled trial in humans with type-2 diabetes. | Redox Biol | 2023 | 37812879 | PubTator, text mining | PubMed |
| LRPPRC regulates malignant behaviors, protects mitochondrial homeostasis, mitochondrial function in osteosarcoma and derived cancer stem-like cells. | BMC Cancer | 2023 | 37789316 | PubTator, text mining | PubMed |
| Exploring the mechanism of metformin action in Alzheimer's disease and type 2 diabetes based on network pharmacology, molecular docking, and molecular dynamic simulation. | Ther Adv Endocrinol Metab | 2023 | 37780174 | PubTator, text mining | PubMed |
| Rewiring of mitochondrial metabolism in therapy-resistant cancers: permanent and plastic adaptations. | Front Cell Dev Biol | 2023 | 37779896 | PubTator, text mining | PubMed |
| Transcriptomic and Physiological Analysis Reveals Genes Associated with Drought Stress Responses in Populus alba × Populus glandulosa. | Plants (Basel) | 2023 | 37765403 | PubTator, text mining | PubMed |
| Identification of Candidate Biomarkers of Alzheimer's Disease via Multiplex Cerebrospinal Fluid and Serum Proteomics. | Int J Mol Sci | 2023 | 37762527 | PubTator, text mining | PubMed |
| Pitfalls of Mitochondrial Redox Signaling Research. | Antioxidants (Basel) | 2023 | 37759999 | PubTator, text mining | PubMed |
| Abnormalities in Copper Status Associated with an Elevated Risk of Parkinson's Phenotype Development. | Antioxidants (Basel) | 2023 | 37759957 | PubTator, text mining | PubMed |
| Expansion of clinico-genetic spectrum of PRDX3 disease: a literature review with two additional cases. | Brain Commun | 2023 | 37731903 | PubTator, text mining | PubMed |
| Mitochondrial Dysfunction in PCOS: Insights into Reproductive Organ Pathophysiology. | Int J Mol Sci | 2023 | 37685928 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/10935/papers?page=8